Navigation Links
Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
Date:4/18/2013

ngs and systemic toxicities, limit its use in a chronic setting. In contrast to the established treatment of Pseudomonas aeruginosa lung infection with inhaled antibiotics, there is no FDA-approved inhaled antibiotic treatment available for MRSA lung infection.

Savara's Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study in 80 CF patients at 22 CF centers nationwide. Patients will receive either 32 mg or 64 mg doses of AeroVanc or a corresponding placebo twice daily for 28 days. The primary objective of the study is to evaluate the efficacy of AeroVanc in reducing the quantity of MRSA colony forming units in the sputum cultures. The secondary objectives include evaluation of the efficacy of AeroVanc in improving lung function, reducing respiratory symptoms reported by the patients, and reducing the use of other antibiotics. Study results are expected in the first quarter of 2014.

"We are encouraged by the recent FDA approval of Novartis' dry-powder TOBI Podhaler for Pseudomonas aeruginosa infections in CF patients. An inhaled dry powder form of vancomycin for MRSA infection will be a logical addition to this and other treatment options available for CF patients," said Rob Neville , CEO of Savara Pharmaceuticals. "We are further encouraged by the strong interest and support of key opinion leaders, and the feedback that AeroVanc is exactly what the CF care community has been waiting for."  

Details of the AeroVanc Phase 2 study can be found at www.clinicaltrials.gov (study identifier NCT01746095).

About AeroVanc

Intravenous vancomycin is the antibiotic of choice for MRSA-related bronchopneumonia, however, the burden of IV administration, poor penetration into the lungs and systemic toxicities limit its use in a chronic setting. AeroVanc (vancomycin hydrochloride inhalation powder) is a proprietary inhaled dry
'/>"/>

SOURCE Savara Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
2. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
3. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
4. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
5. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
6. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
7. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
8. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
9. JHP Pharmaceuticals to Produce Supplies of Biologic Drug Product for Late-Phase Clinical Trials
10. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
11. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 The western European ... It is largely a replacement market with fewer ... mergers, acquisitions and partnerships are redefining competitive landscape ... research service provides details about revenue forecasts, unit ... trends across the country. The changing landscape makes ...
(Date:9/22/2014)... -- Final shortlist announced, winners to ... The second edition of the much-awaited VCCircle Healthcare Awards is round ... final nominations for the 2014 honours.  The names of ... 25 at The Taj Mahal Palace, Mumbai . The ... variety of qualitative and quantitative parameters - such as ...
(Date:9/22/2014)... 22, 2014  Elusys Therapeutics, Inc. (Elusys), a ... disease, today announced it has completed three phase ... (ETI-204). Obiltoxaximab is an anti-toxin in development for ... these studies support the safety and tolerability of ... intended therapeutic dose. The conclusion of these studies ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 2Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6
(Date:9/22/2014)... Career Step, an online provider of ... and exhibiting at the 86th Annual Convention and ... (AHIMA) in San Diego, California. The conference is ... Career Step will be exhibiting in booth 711 ... products, including CLiMâ„¢, its coder lifecycle management solution, ...
(Date:9/22/2014)... Airbus Helicopters Inc. (AHI) honored leaders of the air ... safety and quality of service. The annual Jim Charlson ... award, both sponsored by AHI, were presented to recipients ... , PHI Air Medical President David Motzkin ... given annually to an individual who has made significant ...
(Date:9/22/2014)... The Philadelphia 100, which honors the fastest ... year, is considered a hallmark of entrepreneurship in the ... proud to announce it has earned a spot among ... the Philadelphia 100 awards banquet on October ... of the year, as well as a separate winners-only ...
(Date:9/22/2014)... ANN ARBOR, Mich. A surprising new study pulls ... issues in health care: differences in payment and income ... those who don,t. , Contrary to perception, the ... "rigged" to favor surgeons and other procedure-performing doctors. , ... a simple difference in pay per minute explains why ...
(Date:9/22/2014)... Alan Mozes HealthDay ... Pediatricians, take note: Many American parents are aware of online ... choose a pediatrician for their children, according to a new ... more than 1,600 parents -- further suggest that negative online ... that doctor has been recommended by a neighbor. Conversely, ...
Breaking Medicine News(10 mins):Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 3Health News:MK Precision Announces Spot on Philadelphia 100 Fastest Growing Companies 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3
... DIEGO, Oct. 6 Amira Pharmaceuticals, Inc., a small ... development of new drugs to treat inflammatory disease, announced ... a company overview at the Montgomery Healthcare Conference 2009 ... , Founded in 2005 and headquartered in San ...
... database identifies competitive advantage for employers ... , SAN FRANCISCO, Oct. 6 To help ... Institute (IBI) released today the country,s largest single-source ... non-occupational benefits programs. The 2008 IBI Benchmarking database ...
... receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) ... twice the risk of developing learning and memory problems than ... University of Texas M. D. Anderson Cancer Center. The ... the October 5, 2009 online edition of the Lancet ...
... leading cause of cancer-related deaths in the United States, ... can be prevented with early screening using a procedure ... University, Mayo Clinic and the University of Massachusetts at ... facilities operate more efficiently, ultimately lowering costs and leading ...
... 2009 The action of a small protein that is ... another brain protein, researchers at UT Southwestern Medical Center have ... in the journal Proceedings of the National Academy of ... illness, the researchers said. The harmful protein, called beta-amyloid, ...
... ... the press - the savings that can be made and the quality of the care. ... , ... Medical tourism has been around since the Romans. In recent years however, growing numbers of people ...
Cached Medicine News:Health News:Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 2Health News:Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 3Health News:Stereotactic radiosurgery preferred method of treating cancer patients with brain metastases 2Health News:Stereotactic radiosurgery preferred method of treating cancer patients with brain metastases 3Health News:Study shows how to lower costs, waiting times for colonoscopies 2Health News:New findings about brain proteins suggest possible way to fight Alzheimer's 2Health News:85% of People Would Consider Medical Tourism 2Health News:85% of People Would Consider Medical Tourism 3
... surgical knives single-use blades deliver a ... the low friction coefficient achieved with ... diamond surgical knives feature top-of-the-line, reusable ... capabilities based on the diamond expertise ...
... is a bioresorbable implant that is used ... This proprietary, user-friendly design, shaped like ... fit into burr holes and requires no ... has superior mechanical strength and the scaffold ...
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite....
... heparinized glass capillary devices wrapped ... tubes are used for the ... for the measurement of pH, ... lithium) and can hold up ...
Medicine Products: